|
[Related PubMed/MEDLINE]
Total Number of Papers: 7
|
|
|
|
|
[Display Entries]
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: PEC |
| Long Form |
: Pectolinarigenin |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
Natural Flavonoid Pectolinarigenin Alleviated Hyperuricemic Nephropathy via Suppressing TGFbeta/SMAD3 and JAK2/STAT3 Signaling Pathways. |
HN, UUO |
| 2 |
2022 |
Pectolinarigenin Suppresses LPS-Induced Inflammatory Response in Macrophages and Attenuates DSS-Induced Colitis by Modulating the NF-kappaB/Nrf2 Signaling Pathway. |
CAT, COX-2, DSS, IL-1beta, IL-6, iNOS, LPS, MDA, MPO, NF-kappaB, SOD, TNF-alpha |
| 3 |
2020 |
Natural flavonoid pectolinarigenin alleviated kidney fibrosis via inhibiting the activation of TGFbeta/SMAD3 and JAK2/STAT3 signaling. |
UUO |
| 4 |
2019 |
Pectolinarigenin prevents bone loss in ovariectomized mice and inhibits RANKL-induced osteoclastogenesis via blocking activation of MAPK and NFATc1 signaling. |
CTSK, MMP-9, OP, RANKL, TRACP |
| 5 |
2018 |
Comparative Proteomic Profiling of Tumor-Associated Proteins in Human Gastric Cancer Cells Treated with Pectolinarigenin. |
--- |
| 6 |
2018 |
Pectolinarigenin Induced Cell Cycle Arrest, Autophagy, and Apoptosis in Gastric Cancer Cell via PI3K/AKT/mTOR Signaling Pathway. |
AVOs, IAP, PARP |
| 7 |
2018 |
Pectolinarigenin inhibits non‑small cell lung cancer progression by regulating the PTEN/PI3K/AKT signaling pathway. |
NSCLC, PTEN |
|
A Search Service for Abbreviation / Long Form
